Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
142 studies found for:    "Anal cancer"
Show Display Options
RSS Create an RSS feed from your search for:
"Anal cancer"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Pembrolizumab in Refractory Metastatic Anal Cancer
Condition: Anal Cancer
Intervention: Drug: Pembrolizumab
2 Recruiting Shared Decision Making With Anal Cancer Patients on Radiation Dose
Condition: Anal Cancer
Interventions: Radiation: 2.15 gray and 1.8 gray. Max. 6 weeks.;   Radiation: 2.15 gray and 1.8 gray. Max. 5 weeks.
3 Completed Anal Cancer Screening Study
Condition: Anal Cancer
Intervention:
4 Unknown  Radiation Therapy, Cisplatin, Fluorouracil, and Cetuximab in Treating Patients With Locally Advanced Anal Cancer
Condition: Anal Cancer
Interventions: Biological: cetuximab;   Drug: cisplatin;   Drug: fluorouracil;   Other: laboratory biomarker analysis;   Radiation: radiation therapy
5 Terminated Radiation Therapy, Mitomycin, and Either Fluorouracil or Cisplatin in Treating Patients With Locally Advanced Anal Cancer
Condition: Anal Cancer
Interventions: Drug: cisplatin;   Drug: fluorouracil;   Drug: mitomycin C;   Radiation: radiation therapy
6 Completed Assessing Drivers and Barriers to Follow-Up Screening for Anal Cancer in Men Who Have Sex With Men
Condition: Anal Cancer
Intervention:
7 Recruiting Anal Cancer Radiotherapy Study
Condition: Anal Cancer
Intervention:
8 Completed Radiation Therapy Plus Fluorouracil With or Without Additional Chemotherapy in Treating Patients With Primary Anal Cancer
Condition: Anal Cancer
Interventions: Drug: cisplatin;   Drug: fluorouracil;   Drug: mitomycin C;   Radiation: radiation therapy
9 Recruiting Individual Following in Anal Cancer With PET/CT
Condition: Anal Cancer
Intervention: Other: anal cancer
10 Active, not recruiting A Phase I/II Evaluation of ADXS11-001, Mitomycin, 5-fluorouracil (5-FU) and IMRT for Anal Cancer
Condition: Anal Cancer
Intervention: Biological: Advaxis
11 Recruiting Quality of Life in Patients With Anal Cancer
Condition: Anal Cancer
Intervention:
12 Not yet recruiting A Phase I Study of Photodynamic Therapy (PDT) for High-grade Anal Dysplasia and Microinvasive Anal Cancer
Condition: Anal Cancer
Intervention: Drug: Gliolan
13 Unknown  Predictive Value of FMISO-PET, FDG-PET-CT, DWI-MRI and DCE-MRI Scans for Patients With Anal Cancer Receiving Radiotherapy +/- Chemotherapy
Condition: Anal Cancer
Intervention: Other: FMISO-PET, FDG-PET-CT and Magnetic Resonance Imaging (MRI)
14 Completed
Has Results
Combined Modality Therapy for Patients With With HIV and Stage I, Stage II, or Stage III Anal Cancer
Condition: Anal Cancer
Interventions: Biological: cetuximab;   Drug: cisplatin;   Drug: fluorouracil;   Radiation: radiation therapy
15 Active, not recruiting
Has Results
Cetuximab, Cisplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Anal Cancer
Condition: Anal Cancer
Interventions: Biological: cetuximab;   Drug: cisplatin;   Drug: fluorouracil;   Radiation: radiotherapy
16 Not yet recruiting Functional Outcomes Following Anal Cancer Treatment
Condition: Anal Cancer
Intervention:
17 Completed SGN-00101 in Preventing Anal Cancer in Patients With HIV Who Have Anal Neoplasia
Condition: Anal Cancer
Intervention: Biological: HspE7
18 Recruiting Dose Escalation Trial of Endoluminal High-Dose-Rate Brachytherapy With Concurrent Chemotherapy for Rectal or Anal Cancer in Patients With Recurrent Disease or Undergoing Non-Operative Management
Condition: Rectal or Anal Cancer
Interventions: Radiation: endorectal brachytherapy;   Drug: concurrent capecitabine or 5-FU;   Behavioral: Questionnaires
19 Withdrawn A Prospective, Open-Label, Multi-center Comparison of Lymphoseek Identified Lymph Nodes and Clinically Identified Lymph Nodes of Subjects With Known Cancer of the Anus
Condition: Anal Cancer
Intervention: Drug: Lymphoseek
20 Completed Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
Condition: Anal Cancer
Interventions: Drug: cisplatin;   Drug: fluorouracil;   Drug: mitomycin C;   Radiation: radiation therapy

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.